MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company provides NUMEN Silk, a electronically detachable coil; Numen Li...
MicroPort NeuroScientific opened higher but reversed lower throughout the session, rallying to an intraday high of HKD 11.00 before falling steadily to close at HKD 10.46, down 4.9% with turnover of approximately HKD 32.3 million. The company's recent share buybacks (e.g., at HKD 10.61-10.82 and HKD 10.98) and FDA clearance of the NUMEN Helia Coil were overshadowed by persistent selling pressure in the afternoon, with the stock touching its session low of HKD 10.46 at the close. Q4 2025 net profit fell 13.49% YoY to HKD 50.9 million despite a 20.5% revenue increase to HKD 226.6 million. The stock remains 36.37% below its 52-week high of HKD 16.44 and is down 7.43% YTD, though it trades above both its 20-day (HKD 10.06) and 60-day (HKD 10.09) moving averages. PE and PB stand at 29.11x and 2.99x, respectively. Bank of America Securities recently cut its target price to HKD 13.9 while maintaining a Buy rating.
MicroPort NeuroTech Artemis Dream intracranial rapamycin stent enters NMPA innovative device green channel
MicroPort NeuroScientific announces final dividend of HK$ 0.09 per share, offers scrip option
MicroPort NeuroScientific files HKEX next-day return disclosing share repurchase at HKD 10.98 each
MicroPort NeuroScientific files HKEX next-day return disclosing share buyback at HKD 10.61-10.82
STOCKS | Hong Kong Brain-Computer Interface Shares Fall, Lenovo Down More Than 6%
MicroPort NeuroScientific files HKEX next-day disclosure return, reports share repurchase